01

L'Oréal and Walgreens Back $27.5M Round for Chinese Biomaterials Firm

L'Oréal's BOLD fund and a Walgreens-backed vehicle co-led a $27.5M round for Shenzhen Boyin, whose PAM2L platform pairs synthetic biology with AI for cosmetic biomaterials.